《基于中国人群的EQ-5D-5L量表研究》（2012-2016）：欧洲生命质量小组研究课题

Chinese Population Based EQ-5D-5L Evaluation Study Funded by EuroQol Group

该课题应用欧洲生命质量小组（EuroQol Group）授权使用的EQ-VT工具，在中国北京、南京、沈阳、成都、广州5个城市开展调查，对1250名居民进行生命质量研究，首次构建了基于中国人群偏好的EQ-5D-5L量表健康效用值积分体系，为中国本土开展卫生技术评估奠定了重要的基础。

Using the EuroQol Valuation Technology (EQ-VT) authorized by EuroQol Group, this study is to establish the social value set for EQ-5D-5L instrument based on Chinese general population. With the availability of the value set for cost-utility analysis (CUA), China joins the first five countries that adapt the EQ-VT instrument to conduct economic valuations for health technology assessment.